CNS Pharmaceuticals (CNSP) P/E Ratio
P/E Ratio as of Jun 13, 2025: 0.00
Average0.0000
Median0.0000
Minimum0.0000
Maximum0.0000
0.00
Past Month0.00 (0.00%)
The P/E ratio for CNS Pharmaceuticals (CNSP) is 0.00 as of Jun 13, 2025. This represents a increase of – compared to its 12-month average P/E ratio of 0. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
CNS Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
CNS Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing CNS Pharmaceuticals to industry peers.
CNS Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
CNS Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing CNS Pharmaceuticals to industry peers.
CNS Pharmaceuticals (CNSP) P/E Ratio Insights
See CNS Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CNS Pharmaceuticals (CNSP)
Order type
Buy in
Order amount
Est. shares
0 shares
CNS Pharmaceuticals (CNSP) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $1.00 | 0.00 |
| May 1, 2025 | $1.06 | 0.00 |
| Apr 1, 2025 | $1.29 | 0.00 |
| Mar 3, 2025 | $2.20 | 0.00 |
| Feb 3, 2025 | $4.81 | 0.00 |
| Jan 2, 2025 | $5.845 | 0.00 |
CNS Pharmaceuticals (CNSP) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | -100.00% |
| 2023 | -0.15 | -34.78% |
| 2022 | -0.23 | -82.44% |
| 2021 | -1.31 | -58.15% |
| 2020 | -3.13 | — |
FAQs About CNS Pharmaceuticals (CNSP) P/E ratio
The latest P/E ratio of CNS Pharmaceuticals (CNSP) is 0.00, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
CNS Pharmaceuticals’s last 12-month average P/E ratio is 0, compared to its current P/E ratio of 0.00. This reflects a increase of –.
CNS Pharmaceuticals’s current P/E ratio of 0.00 is higher than its last 12-month average P/E of 0. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
CNS Pharmaceuticals’s average P/E ratio over the last 3 years is -0.16. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
CNS Pharmaceuticals’s average P/E ratio over the last 5 years is -1.19. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.